Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034033 · ClinicalTrials.gov registry record
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
A clinical trial of Breast Cancer and Ovarian Cancer, sponsored by Stanford University.
- Recruiting
- Registry status
- 3,300
- Enrollment target
- 1
- Study location
NCT01034033: Recruiting study of Breast Cancer and Ovarian Cancer, sponsored by Stanford University.
NCT01034033 is a study of Breast Cancer and Ovarian Cancer that is actively recruiting participants, run by Stanford University. The registered enrollment target is 3,300 participants, above the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01034033, a study of Breast Cancer and Ovarian Cancer, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 3,300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to try to understand the biology of development of breast, ovarian, fallopian tube, peritoneal or endometrial cancer from persons at high genetic risk for these diseases. The influence of environmental factors on cancer development in individuals and families will be studied. The efficacy of treatments for these diseases will be evaluated.
Conditions Studied
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,300 participants |
| Start Date | 2001-08 |
| Est. Completion | 2099-01 |
What NCT01034033 shows while recruiting
NCT01034033 is an observational study that tracks outcomes without assigning an intervention. Its 3,300 participants enrollment target places it among the larger protocols in the corpus, above the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (18% higher).
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01034033 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01034033 about?
NCT01034033 is a clinical study titled "Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples". The purpose of this study is to try to understand the biology of development of breast, ovarian, fallopian tube, peritoneal or endometrial cancer from persons at high genetic risk for these diseases. The influence of environmental factors on cancer development in individuals and families will be stu...
What is the current status of trial NCT01034033?
This trial is currently recruiting. The enrollment target is 3,300 participants. The study started on 2001-08. Estimated completion is 2099-01.
What conditions does trial NCT01034033 study?
This clinical trial studies the following conditions: Breast Cancer, Ovarian Cancer, Gynecologic Cancers, Ovarian/Peritoneal/Fallopian Cancer.
Who is sponsoring clinical trial NCT01034033?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01034033 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01034033's enrollment target sits among peer trials
3,300 43rd of 1224 higher than 1,181 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03674307 · 3,306 participants · NA
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
- NCT06815536 · 3,291 participants
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
- NCT06543446 · 3,290 participants · NA
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
- NCT04077762 · 3,266 participants · NA
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia